News - Mergers & Acquisitions, Oncology


Popular Filters

76 to 93 of 93 results

AstraZeneca completes sale of Aptium Oncology assets


Anglo-Swedish drug major AstraZeneca (LSE: AZN) says that it has completed the previously indicated sale…

Aptium OncologyAstraZenecaMergers & AcquisitionsOncologyPharmaceutical

Spectrum extends tender offer for Allos


US biotech firm Spectrum Pharmaceuticals (Nasdaq: SPPI) said late Friday that it has again extended tender…

Allos TherapeuticsBiotechnologyFolotynMergers & AcquisitionsOncologySpectrum Pharmaceuticals

News briefs: GlaxoSmithKline and Bayer


UK pharma giant GlaxoSmithKline (LSE: GSK) has said it would not proceed with its $2.59 billion hostile…

Antibiotics and Infectious diseasesBayerGlaxoSmithKlineMergers & AcquisitionsOncologyPharmaceuticalregorafenibRegulationResearch

Agilent to acquire cancer diagnostics firm Dako for $2.2 billion


USA-based Agilent Technologies (NYSE: A) and EQT, a Swedish private equity group, have entered into an…

AgilentDakoMergers & AcquisitionsOncologyPharmaceutical

Spectrum plunges on negative trial results; makes bid for Allos


US biotech firm Spectrum Pharmaceuticals (Nasdaq: SPPI) saw its shares plunge as much as 14%, before…

Allos TherapeuticsapaziquoneBiotechnologyFolotynMergers & AcquisitionsOncologyPharmaceuticalResearchSpectrum Pharmaceuticals

Shire to acquire FerroKin BioSciences; drops Replagal BLA


Ireland-headquartered Shire (LSE: SHP) said yesterday that it has signed an agreement to acquire privately-held…

FerroKin BioSciencesMergers & AcquisitionsNorth AmericaOncologyPharmaceuticalRare diseasesRegulationReplagalShire

Dainippon Sumitomo to acquire Boston Biomedical


Japanese drugmaker Dainippon Sumitomo Pharma (4506: JP) says it has reached an agreement for the acquisition…

BiotechnologyMergers & AcquisitionsOncologyPharmaceutical

Riemser strengthens oncology range with Roche drug


German drugmaker Riemser Arzneimittel AG is extending its range of supportive cancer therapy products…

Mergers & AcquisitionsOncologyOstacPharmaceuticalRiemser ArztneimittelRoche

Amgen to acquire US/German biotech firm


Adding to the strong start this year for M&A activity in the Pharma/Biotech sector, USA-based Amgen (Nasdaq:…

AmgenBiotechnologyMergers & AcquisitionsMicrometOncology

Celgene to buy Avila; posts strong 4th-qtr results


USA-based Celgene (Nasdaq: CELG) yesterday revealed that it has entered into a definitive merger deal…

Avila TherapeuticsBiotechnologyCelgeneFinancialMergers & AcquisitionsOncologyPharmaceutical

Spectrum Pharma to acquire non-US rights to market Zevalin


USA-based Spectrum Pharmaceuticals (NasdaqGS: SPPI) says it has entered into an agreement to acquire…

BayerMergers & AcquisitionsOncologyPharmaceuticalSpectrum PharmaceuticalsZevalin

Roche in epigenetics drug discovery collaboration


USA-based Constellation Pharmaceuticals says that it has entered into a major strategic agreement with…

BiotechnologyConstellation PharmaceuticalsGenentechLicensingMergers & AcquisitionsOncologyPharmaceuticalRoche

RusNano to start production of vaccines and organogels


Russia’s RusNano (Russian Corporation of Nanotechnologies) has signed an agreement with Russian…

Anti-viralsBiotechnologyCardio-vascularEpidbiomedEuropeFinancialMarkets & MarketingMergers & AcquisitionsNanolekOncologyRusNanoVaccines

Apricus Biosciences closes Topotarget USA acquisition


Apricus Biosciences (Nasdaq: APRI) has closed its previously-announced acquisition of Topotarget USA,…

Apricus BioscienceMergers & AcquisitionsOncologyPharmaceuticalTopotargetTotect

Takeda boosts oncology pipeline with acquisition


Japan’s largest drugmaker Takeda Pharmaceutical (TYO: 4502), via a US subsidiary, has entered into…

IntellikineMergers & AcquisitionsOncologyPharmaceuticalTakeda Pharmaceuticals

Akorn in up to $58 million deal to acquire certain assets of India’s Kilitch Drugs and NBZ Pharma


US niche generics maker Akorn (Nasdaq: AKRX) has entered into an agreement to acquire certain assets…

AkornAntibiotics and Infectious diseasesAsia-PacificGenericsKilitch DrugsMergers & AcquisitionsOncologyOphthalmics

Teva ups stake in CureTech to 75% following positive clinical results in lymphoma


Israel-based Teva Pharmaceutical Industries (Nasdaq: TEVA) says it is exercising its option to make an…

CureTechGenericsMergers & AcquisitionsOncologyPharmaceuticalResearchTeva Pharmaceutical Industries

76 to 93 of 93 results

Back to top